Fundraising

HK-based biotech startup gets venture capital injection

Insilico Medicine wants to speed up the process of drug development with its AI technology - and it is already doing so with the help of WuXi AppTech.

Qiming Venture Partners has led Series B fundraising for Hong Kong-based Insilico Medicine, which hopes to speed up the process of drug development with artificial intelligence.

¬ Haymarket Media Limited. All rights reserved.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media